Economic burden of severe asthma in turkey: A cost of illness study from payer perspective
No Thumbnail Available
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Objective. To estimate economic burden of severe asthma in Turkey from payer perspective based on expert panel opinion on practice patterns in clinical practice. Methods. This cost of illness study was based on identification of per patient annual direct medical costs for the management of severe asthma in Turkey from payer perspective. Average per patient direct medical cost was calculated based on cost items related to outpatient visits, laboratory and radiological tests, hospitalizations and interventions, drug treatment and equipment, and co-morbidities/complications. Results. Based on total annual per patient costs calculated for outpatient admission ($ 177.91), laboratory and radiological tests ($ 82.32), hospitalizations/interventions ($ 1,154.55), drug treatment/equipment ($ 2,289.63) and co-morbidities ($ 665.39) cost items, total per patient annual direct medical cost related to management of severe asthma was calculated to be $ 4,369.76 from payer perspective. Drug treatment/equipment (52.4%) was the main cost driver in the management of severe asthma in Turkey, as followed by hospitalizations/interventions (26.4%) and co-morbidities (15.2%). Conclusions. In conclusion, our findings indicate that managing patients with severe asthma pose a considerable burden to health economics in Turkey, with medications as the main cost driver. © 2021 Associazione Allergologi Immunologi Italiani Territoriali e Ospedalieri-AAIITO. Published by EDRA SpA. All rights reserved.
Description
Keywords
Adult , Anti-Asthmatic Agents , Asthma , Cost of Illness , Cost-Benefit Analysis , Costs and Cost Analysis , Female , Financial Stress , Health Care Costs , Hospitalization , Humans , Male , Middle Aged , Practice Patterns, Physicians' , Severity of Illness Index , Turkey , antiasthmatic agent , antiasthmatic agent , Article , asthma , clinical practice , comorbidity , computer assisted tomography , controlled study , cost of illness , diagnostic imaging , disease burden , disease severity , health care cost , health insurance , hospital admission , hospitalization , human , laboratory test , outpatient care , patient care , prescription , thorax radiography , Turkey (republic) , adult , asthma , cost , cost benefit analysis , economics , female , male , middle aged , severity of illness index , turkey (bird)